The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Trial
Sign Up to like & getrecommendations! Published in 2020 at "JACC: Basic to Translational Science"
DOI: 10.1016/j.jacbts.2020.05.002
Abstract: O n April 29, the National Institute of Health disclosed the preliminary findings of the ACTT-1 (Adaptive COVID-19 Treatment Trial) (NCT04280705), the first clinical trial in the United States to evaluate an experimental treatment for… read more here.
Keywords: national institute; trial; adaptive covid; covid ... See more keywords
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac219
Abstract: Abstract Background The Adaptive COVID Treatment Trial-2 (ACTT-2) found that baricitinib in combination with remdesivir therapy (BCT) sped recovery in hospitalized coronavirus disease 2019 (COVID-19) patients vs remdesivir monotherapy (RMT). We examined how BCT affected… read more here.
Keywords: adaptive covid; effect; utilization; bct ... See more keywords